Global Infectious Disease Molecular Diagnostics Market Grows Tremendously at a CAGR of 6.5%

Regarding infectious diseases, molecular diagnostic assays seek to improve the diagnostic accuracy of the underlying disease. After the target has been amplified, it is standard practice to identify the organism using a nucleic acid probe. These remedies are effective against infections caused by bacteria, fungi, and parasites. When investigating infectious diseases, molecular diagnostic technologies excel at identifying specific microorganisms. A lymph node, for example, may exhibit symptoms of cat-scratch disease (CSD), but the pathologist must first eliminate all other possibilities.

Combining conventional laboratory testing with the precision of molecular biology has transformed the way clinical and public health laboratories investigate the human, viral, and microbial genomes and the genes and proteins they encode. This revolution is centered on molecular diagnostics. Molecular diagnostic is a collection of widely employed, highly effective, and sensitive methods for identifying biological markers in a genome and proteome.

Market Dynamics

Introduction of Technologically Advanced Products Drive the Global Market

This industry is anticipated to be propelled by rapid technological advancements that generate precise results, portability, and cost-effectiveness. Businesses are enhancing their products to obtain precise results. Key participants are expanding their qPCR testing options by conducting R&D to create kits that target emerging diseases or by signing agreements with other kit-manufacturing companies. Among them is Roche Diagnostics' incorporation of the Cobas HPV test assay into the Cobas 4800.

Cepheid's edition of the Expert Assay for tuberculosis diagnostics to its GeneXpert platform represents an expansion. As a result of these developments, the global market for molecular diagnostics for infectious diseases is anticipated to expand. Increasing adoption of ELISA and Fluorescence in Situ Hybridization (FISH) technologies is also expected to fuel market expansion over the forecast period.

Expanding Possibilities in Expanding Economies Creates Tremendous Opportunities

In the not-too-distant future, expanding economies such as India, South Korea, Brazil, and Mexico will present growth opportunities for the current market leaders in infectious disease diagnostics. This conclusion can be attributed to several factors, including a high disease prevalence, a large patient population, an enhanced healthcare infrastructure, increased disposable income, and medical tourism in these countries.

In addition to the previously mentioned factors, the Asia-Pacific region has become a flexible and business-friendly hub due to significantly less stringent data and rule requirements. This is one of the factors contributing to the region's recognition. This has played a crucial role in the region's development.

Regional Analysis

North America is the most significant global Infectious Disease Molecular Diagnostics market shareholder and is estimated to exhibit a CAGR of 15.24% over the forecast period. The rising health consciousness among clients and growing demand for highly nutritious products drive the region's adoption of Infectious Disease Molecular Diagnostics products. People are facing lifestyle disorders due to changes in lifestyle and irregularities in nutrition consumption, which also triggers the demand for Infectious Disease Molecular Diagnostics products. The market is expected to expand during the forecast period due to the growing use of nutritional products to maintain and improve the immune system. Furthermore, factors such as the increasing popularity of digital solutions and preference for customized diet plans drive the market's growth. Poor dietary choices are one of the key factors for the increasing prevalence of lifestyle diseases in the region.

Europe is anticipated to exhibit a CAGR of 13.94% over the forecast period. The expansion of Infectious Disease Molecular Diagnostics in this area is driven by the rising trend of customizing food to achieve a healthier diet, awareness of healthy foods, and promoting health and nutrition. The personalized approach toward health and wellness helps achieve specific goals within a specified time frame. Furthermore, the increasing innovations in customer-facing technologies give customers access to information about customized nutritional solutions. The region's growing popularity of Infectious Disease Molecular Diagnostics has caused a major shift in food consumption patterns. The rising demand for natural foods is also a key factor in the market. Moreover, market players are constantly working on Infectious Disease Molecular Diagnostics and health products, which will drive the Infectious Disease Molecular Diagnostics market in this region.

Key Highlights

• The global infectious disease molecular diagnostics market size was valued at USD 35.5 billion in 2022. It is estimated to reach USD 62.58 billion by 2031, growing at a CAGR of 6.5% during the forecast period (2023–2031).
• Based on the product, the global infectious disease molecular diagnostics market is bifurcated into instruments, reagents, and services. The reagents segment dominates the global market and is predicted to exhibit a CAGR of 3.1% over the forecast period.
• Based on application, the global infectious disease molecular diagnostics market is bifurcated into respiratory diseases, tuberculosis, meningitis, gastrointestinal tract infections, HPV, sexually transmitted infections, sepsis, drug resistance disease, and other infectious disease. The Sexually transmitted infections segment owns the highest market share and is predicted to exhibit a CAGR of 9.39% during the forecast period.
• Based on technology, the global infectious disease molecular diagnostics market is divided into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), chips and microarrays, mass spectrometry, sequencing, transcription-mediated amplification, and others. The polymerase chain reaction (PCR) segment is the most significant contributor to the market and is estimated to exhibit a CAGR of 2.1% over the forecast period.
• Based on end-users, the global infectious disease molecular diagnostics market is divided into hospitals, clinics, diagnostics laboratories, and research institutes. The diagnostics laboratories segment is the most significant contributor to the market and is estimated to exhibit a CAGR of 1.4% over the forecast period.
• North America is the most significant global Infectious Disease Molecular Diagnostics market shareholder and is estimated to exhibit a CAGR of 15.24% over the forecast period.

Market Segments

Global Infectious Disease Molecular Diagnostics Market: Segmentation

By Product

• Instruments
• Reagents
• Services

By Applications

• Respiratory Diseases
• Tuberculosis
• Meningitis
• Gastrointestinal Tract Infections
• HPV
• Sexually Transmitted Infections
• Sepsis
• Drug Resistance Disease
• Other Infectious Diseases

By Technology

• Polymerase chain reaction (PCR)
• In Situ Hybridization
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• Chips and Microarrays
• Mass Spectrometry
• Sequencing
• Transcription Mediated Amplification
• Others

By End-User

• Hospitals
• Clinics
• Diagnostics Laboratories
• Research Institutes

By Regions

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East and Africa